{"nctId":"NCT01007110","briefTitle":"Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes","startDateStruct":{"date":"2009-05"},"conditions":["Pregnancy"],"count":67,"armGroups":[{"label":"Docosahexaenoic Acid (DHA)","type":"ACTIVE_COMPARATOR","interventionNames":["Dietary Supplement: DHA"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"DHA","otherNames":["Docosahexaenoic acid"]},{"name":"Placebo","otherNames":["Algal oil"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Pregnant females 16.0-35.99 years of age who are 12 to 20 weeks gestation at the time of enrollment (by dates or ultrasound)\n* Agree to consume study capsules from enrollment until delivery\n* BMI \\<40 at baseline or weight does not exceed 300 pounds\n* No serious illnesses likely to confound study outcomes\n* Available by phone\n\nExclusion Criteria:\n\n* Less than 16 or greater than 35.99 years of age at enrollment\n* BMI \\>40 at baseline\n* Any serious illness likely to confound primary study outcomes\n* Expecting multiple infants\n* Diabetes (Type I, II or gestational) at baseline\n* Elevated blood pressure due to any cause (systolic BP \\>= 140 mm Hg\n* Gestational age at baseline \\< 12 weeks or \\> 20 weeks\n* Unable to provide informed consent in English","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"16 Years","maximumAge":"35 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Heart Rate","description":"Mean fetal heart rate calculated from the magnetocardiogram recorded at 24, 32 and 36 weeks gestational age.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"146.0","spread":"6.5"},{"groupId":"OG001","value":"145.2","spread":"6.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"142.5","spread":"7.7"},{"groupId":"OG001","value":"140.8","spread":"7.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"145.0","spread":"8.6"},{"groupId":"OG001","value":"141.7","spread":"9.3"}]}]}]},{"type":"SECONDARY","title":"Neonatal Behavioral Assessment Scale (NBAS) Scores","description":"The Neonatal Behavioral Assessment Scale (NBAS) measure 6 areas.\n\nFor behavioral items a higher score corresponds to more desirable outcomes:\n\n1. Habituation: Sum of scores across 3 items, scored on a scale of 1-9. Range: 3-27.\n2. Orientation: Sum of scores across 7 items, scored on a scale of 1-9. Range: 7 - 63.\n3. Motor: Sum of scores across 5 items; 3 scored on a scale of 1-9, 1 scored on a scale of 1-6, and 1 scored on a scale of 1-5. Range: 5-38.\n4. Range of State: Sum of scores across 4 items; 2 scored on a scale of 1-6 and 2 scored on a scale of 1-5. Range: 4-22.\n5. Regulation of State: Sum of scores across 4 items, scored on a scale of 1-9. Range: is 4-36.\n6. Autonomic Stability: Sum of scores across 3 items; 1 scored on a scale of 1-9, 1 on a scale of 1-8, and 1 on a scale of 1-6. Range: 3-23.\n\nReflexes: Sum across the 18 items, scored on a scale of 0-3. Range: 0 to 54. The supplementary items are each scored on a scale of 1-9 and do not combine to form a composite.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.92","spread":"9.28"},{"groupId":"OG001","value":"8.47","spread":"9.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.75","spread":"15.45"},{"groupId":"OG001","value":"23.40","spread":"18.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.08","spread":"11.40"},{"groupId":"OG001","value":"26.07","spread":"18.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.50","spread":"13.89"},{"groupId":"OG001","value":"15.13","spread":"8.02"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.42","spread":"20.02"},{"groupId":"OG001","value":"16.93","spread":"20.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.83","spread":"16.90"},{"groupId":"OG001","value":"18.13","spread":"14.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.92","spread":"14.45"},{"groupId":"OG001","value":"22.60","spread":"14.33"}]}]}]},{"type":"SECONDARY","title":"Maternal Red Blood Cell (RBC) Phospholipids at Delivery","description":"Maternal red blood cell phospholipid collected at delivery. These results were compared to baseline red blood cell phospholipid that was collected at study enrollment. A weighed standard fatty acid mixture (Supelco 37 component fatty acid methyl ester mix,Sigma Aldrich) was employed to correct final DHA weight percent of total fatty acids (wt%TFA).","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.99","spread":null},{"groupId":"OG001","value":"7.09","spread":null}]}]}]},{"type":"SECONDARY","title":"Cord Blood Phospholipids DHA","description":"Newborn red blood cell phospholipids collected at birth.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.18","spread":null},{"groupId":"OG001","value":"7.75","spread":null}]}]}]},{"type":"SECONDARY","title":"Cardiac Conduction Time","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.98","spread":"3.62"},{"groupId":"OG001","value":"39.49","spread":"2.798"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":[]}}}